{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:00:45Z","timestamp":1789725645258,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T00:00:00Z","timestamp":1369353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10151-013-1017-8","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T15:55:41Z","timestamp":1369324541000},"page":"555-559","source":"Crossref","is-referenced-by-count":23,"title":["The association between prucalopride efficacy and constipation type"],"prefix":"10.1007","volume":"17","author":[{"given":"A. M.","family":"Jadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Mcmullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Chapple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,24]]},"reference":[{"key":"1017_CR1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1572-0241.2004.04114.x","volume":"99","author":"PD Higgins","year":"2004","unstructured":"Higgins PD, Johanson JF (2004) Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 99:750\u2013759","journal-title":"Am J Gastroenterol"},{"key":"1017_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-230X-8-5","volume":"8","author":"G Peppas","year":"2008","unstructured":"Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME (2008) Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol 8:5","journal-title":"BMC Gastroenterol"},{"key":"1017_CR3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3109\/00365529709002985","volume":"32","author":"A Glia","year":"1997","unstructured":"Glia A, Lindberg G (1997) Quality of life in patients with different types of functional constipation. Scand J Gastroenterol 32:1083\u20131089","journal-title":"Scand J Gastroenterol"},{"key":"1017_CR4","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1111\/j.1572-0241.2002.05843.x","volume":"97","author":"EJ Irvine","year":"2002","unstructured":"Irvine EJ, Ferazzi S, Pare P, Thompson WG, Rance L (2002) Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol 97:1986\u20131993","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. II","key":"1017_CR5","first-page":"181","volume":"58","author":"J Tack","year":"2009","unstructured":"Tack J, Dubois D, Schenk F (2009) Only 27% of patients with chronic constipation are satisfied with current treatment options. Gut 58(Suppl. II):181","journal-title":"Gut"},{"key":"1017_CR6","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterology 130:1480\u20131491","journal-title":"Gastroenterology"},{"key":"1017_CR7","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1053\/j.gastro.2005.11.064","volume":"130","author":"AE Bharucha","year":"2006","unstructured":"Bharucha AE, Wald A, Enck P, Rao S (2006) Functional anorectal disorders. Gastroenterology 130:1510\u20131518","journal-title":"Gastroenterology"},{"key":"1017_CR8","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1053\/gast.2002.37095","volume":"123","author":"DA Drossman","year":"2002","unstructured":"Drossman DA, Camilleri M, Mayer EA, Whitehead WE (2002) AGA technical review on irritable bowel syndrome. Gastroenterology 123:2108\u20132131","journal-title":"Gastroenterology"},{"key":"1017_CR9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2002.01195.x","volume":"16","author":"AM Schryver De","year":"2002","unstructured":"De Schryver AM, Andriesse GI, Samsom M, Smout AJ, Gooszen HG, Akkermans LM (2002) The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers. Aliment Pharmacol Ther 16:603\u2013612","journal-title":"Aliment Pharmacol Ther"},{"key":"1017_CR10","unstructured":"National Institute for Health and Clinical Excellence. TA211 Constipation (women)\u2014prucalopride: guidance. 15 Dec 2010"},{"key":"1017_CR11","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMoa0800670","volume":"358","author":"M Camilleri","year":"2008","unstructured":"Camilleri M, Kerstens R, Rykx A, Vandeplassche L (2008) A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 358:2344\u20132354","journal-title":"N Engl J Med"},{"key":"1017_CR12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2036.2008.03884.x","volume":"29","author":"EM Quigley","year":"2009","unstructured":"Quigley EM, Vandeplassche L, Kerstens R, Ausma J (2009) Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation \u2013 a 12-week, randomized, double-blind, placebo- controlled study. Aliment Pharmacol Ther 29:315\u2013328","journal-title":"Aliment Pharmacol Ther"},{"key":"1017_CR13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/gut.2008.162404","volume":"58","author":"J Tack","year":"2009","unstructured":"Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L (2009) Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 58:357\u2013365","journal-title":"Gut"},{"key":"1017_CR14","first-page":"30","volume":"30","author":"A Attaluri","year":"2006","unstructured":"Attaluri A, Rao S (2006) Diagnostic and therapeutic approaches to patients with constipation. Practical Gastroenterol 30:30\u201347","journal-title":"Practical Gastroenterol"},{"key":"1017_CR15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1572-0241.2008.01808.x","volume":"103","author":"WD Chey","year":"2008","unstructured":"Chey WD, Pare P, Viegas A, Ligozio G, Shetzline MA (2008) Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial. Am J Gastroenterol 103:1217\u20131225","journal-title":"Am J Gastroenterol"},{"key":"1017_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/tcrm.2007.3.1.107","volume":"3","author":"P Layer","year":"2007","unstructured":"Layer P, Keller J, Loeffler H, Kreiss A (2007) Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom. Ther Clin Risk Manag 3:107\u2013118","journal-title":"Ther Clin Risk Manag"},{"key":"1017_CR17","doi-asserted-by":"crossref","unstructured":"Evans BW, Clark WK, Moore DJ, Whorwell PJ (2007) Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database Syst Rev CD003960","DOI":"10.1002\/14651858.CD003960.pub3"},{"key":"1017_CR18","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1046\/j.1365-2036.2002.01372.x","volume":"16","author":"J Novick","year":"2002","unstructured":"Novick J, Miner P, Krause R et al (2002) A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 16:1877\u20131888","journal-title":"Aliment Pharmacol Ther"},{"key":"1017_CR19","unstructured":"US FDA public health advisory tegaserod maleate (marketed Zelnorm\u2122). http:\/\/www.fda.gov\/CDER\/DRUG\/advisory\/tegaserod.htm . (Accessed July 2008)"},{"key":"1017_CR20","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1136\/gut.28.10.1242","volume":"28","author":"JJ Bannister","year":"1987","unstructured":"Bannister JJ, Davidson P, Timms JM, Gibbons C, Read NW (1987) Effect of stool size and consistency on defaecation. Gut 28:1242\u20131245","journal-title":"Gut"},{"key":"1017_CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10620-011-1848-y","volume":"57","author":"G Bassotti","year":"2012","unstructured":"Bassotti G, Villanacci V, Nascimbeni R et al (2012) Increase of colonic mast cells in obstructed defaecation and their relationship with enteric glia. Dig Dis Sci 57:65\u201371","journal-title":"Dig Dis Sci"},{"key":"1017_CR22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2982.2011.01850.x","volume":"24","author":"G Bassotti","year":"2012","unstructured":"Bassotti G, Villanacci V, Bellomi A et al (2012) An assessment of enteric nervous system and estroprogestinic receptors in obstructed defecation associated with rectal intussusception. Neurogastroenterol Mot 24:155\u2013161","journal-title":"Neurogastroenterol Mot"},{"key":"1017_CR23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/modpathol.3800748","volume":"20","author":"G Bassotti","year":"2007","unstructured":"Bassotti G, Villanacci V, Nascimbeni R et al (2007) Colonic neuropathological aspects in patients with intractable constipation due to obstructed defecation. Mod Pathol 20:367\u2013374","journal-title":"Mod Pathol"},{"key":"1017_CR24","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00464-005-0485-y","volume":"20","author":"A D\u2019Hoore","year":"2006","unstructured":"D\u2019Hoore A, Penninckx F (2006) Laparoscopic ventral recto(colpo)pexy for rectal prolapse: surgical technique and outcome for 109 patients. Surg Endosc 20:1919\u20131923","journal-title":"Surg Endosc"},{"key":"1017_CR25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1463-1318.2007.01259.x","volume":"10","author":"S Slawik","year":"2008","unstructured":"Slawik S, Soulsby R, Carter H, Payne H, Dixon AR (2008) Laparoscopic ventral rectopexy, posterior colporrhaphy and vaginal sacrocolpopexy for the treatment of recto-genital prolapse and mechanical outlet obstruction. Colorectal Dis 10:138\u2013143","journal-title":"Colorectal Dis"},{"key":"1017_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1463-1318.2009.02049.x","volume":"12","author":"R Collinson","year":"2010","unstructured":"Collinson R, Wijffels N, Cunningham C, Lindsey I (2010) Laparoscopic ventral rectopexy for internal rectal prolapse: short-term functional results. Colorectal Dis 12:97\u2013104","journal-title":"Colorectal Dis"},{"key":"1017_CR27","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s10350-008-9434-x","volume":"51","author":"PA Lehur","year":"2008","unstructured":"Lehur PA, Stuto A, Fantoli M et al (2008) ODS II Study Group. Outcomes of stapled transanal rectal resection versus biofeedback for the treatment of outlet obstruction associated with rectal intussusception and rectocele: a multicenter, randomized, controlled trial. Dis Colon Rectum 51:1739","journal-title":"Dis Colon Rectum"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-013-1017-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10151-013-1017-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-013-1017-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T01:56:28Z","timestamp":1715392588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10151-013-1017-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,24]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["1017"],"URL":"https:\/\/doi.org\/10.1007\/s10151-013-1017-8","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"value":"1123-6337","type":"print"},{"value":"1128-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,24]]}}}